A comparative study of phenotypic and genotypic first- and second-line drug resistance testing of Mycobacterium tuberculosis

被引:7
|
作者
Sakhaee, Fatemeh [1 ]
Ghazanfari, Morteza [1 ]
Ebrahimzadeh, Nayereh [1 ]
Vaziri, Farzam [1 ,2 ]
Jamnani, Fatemeh Rahimi [1 ,2 ]
Davari, Mehdi [1 ]
Gharibzadeh, Safoora [3 ,4 ]
Mandjin, Fatemeh Hemati [1 ]
Fateh, Abolfazi [1 ,2 ]
Siadat, Seyed Davar [1 ,2 ]
机构
[1] Pasteur Inst Iran, Dept Mycobacteriol & Pulm Res, Tehran, Iran
[2] Pasteur Inst Iran, MRC, Tehran, Iran
[3] Pasteur Inst Iran, Res Ctr Emerging & Reemerging Infect Dis, Tehran, Iran
[4] Pasteur Inst Iran, Dept Epidemiol & Biostat, Tehran, Iran
关键词
First- and second-line drugs; Mycobacterium tuberculosis; Nitrate reductase assay; Proportion method; Direct sequencing; NITRATE REDUCTASE ASSAY; COST COLORIMETRIC METHODS; RAPID DETECTION; MULTIDRUG-RESISTANCE; PREVALENCE; MULTICENTER; PERFORMANCE; KANAMYCIN; RESAZURIN; RIFAMPIN;
D O I
10.1016/j.biologicals.2017.07.003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to evaluate the frequency of resistance to first- and second-line drugs using phenotypic and genotypic methods and its correlation with resistance-linked mutations in Mycobacterium tuberculosis (M. tb) isolated in Iran. Three different methods, including the indirect proportion method(PM), direct and indirect nitrate reductase assay(NRA), and direct sequencing were used to assess drug resistance. In this study, sensitivity, specificity, agreement, costs, and turnaround time of these methods were compared in 395 smear positive isolates. Compared to the PM, the NRA and the direct sequencing methods demonstrated higher specificity, sensitivity, and agreement for detection of all anti-tuberculosis drugs. The NRA had a short turnaround time and was more cost-effective than the other methods. Mutations in codon 531 in ipoB, 315 in katG,18 in rpsL, and 306 in embB were associated with high-level resistance to the first-line drugs, and mutations in codon 94 in gyrA, and A1401G in rrs were correlated with resistance to the second-line drugs. We found that the NRA is a highly sensitive, specific, inexpensive, and rapid test with strong potential to be a useful and interesting alternative tool, particularly in low-income countries. In addition, these molecular data will be helpful for developing new molecular methods for detecting first- and second-line drug-resistant M. tb. (C) 2017 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 50 条
  • [1] Comparative Study on Genotypic and Phenotypic Second-Line Drug Resistance Testing of Mycobacterium tuberculosis Complex Isolates
    van Ingen, Jakko
    Simons, Sami
    de Zwaan, Rina
    van der Laan, Tridia
    Kamst-van Agterveld, Miranda
    Boeree, Martin J.
    van Soolingen, Dick
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (08) : 2749 - 2753
  • [2] Detection of First- and Second-Line Drug Resistance in Mycobacterium tuberculosis Clinical Isolates by Pyrosequencing
    Engstrom, Anna
    Morcillo, Nora
    Imperiale, Belen
    Hoffner, Sven E.
    Jureen, Pontus
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (06) : 2026 - 2033
  • [3] Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis
    Campbell, Patricia J.
    Morlock, Glenn P.
    Sikes, R. David
    Dalton, Tracy L.
    Metchock, Beverly
    Starks, Angela M.
    Hooks, Delaina P.
    Cowan, Lauren S.
    Plikaytis, Bonnie B.
    Posey, James E.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (05) : 2032 - 2041
  • [4] First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia
    Tessema, B.
    Beer, J.
    Emmrich, F.
    Sack, U.
    Rodloff, A. C.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (06) : 805 - 811
  • [5] Utility of Phenotypic and Genotypic Testing in the Study of Mycobacterium tuberculosis Resistance to First-Line Anti-Tuberculosis drugs
    Alba Alvarez, Luz Maria
    Garcia Garcia, Jose Maria
    Dolores Perez Hernandez, M.
    Martinez Gonzalez, Susana
    Palacios Gutierrez, Juan Jose
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2017, 53 (04): : 192 - 198
  • [6] Sensititre MYCOTB MIC Plate for Testing Mycobacterium tuberculosis Susceptibility to First- and Second-Line Drugs
    Lee, Jongseok
    Armstrong, Derek T.
    Ssengooba, Willy
    Park, Jeong-Ae
    Yu, Yeuni
    Mumbowa, Francis
    Namaganda, Carolyn
    Mboowa, Gerald
    Nakayita, Germine
    Armakovitch, Sandra
    Chien, Gina
    Cho, Sang-Nae
    Via, Laura E.
    Barry, Clifton E., III
    Ellner, Jerrold J.
    Alland, David
    Dorman, Susan E.
    Joloba, Moses L.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (01) : 11 - 18
  • [7] Clinical Validation of the QMAC-DST System for Testing the Drug Susceptibility of Mycobacterium tuberculosis to First- and Second-Line Drugs
    Lee, Sangyeop
    Chu, Daehyun
    Choi, Youn Mi
    Jo, EunJi
    Kim, Suyeoun
    Kim, Haeun
    Kim, Hyun Jung
    Chang, Jeonghyun
    Sung, Heungsup
    Kang, Geumrae
    Jin, Bonghwan
    Kim, Eun-Geun
    Kwon, Sunghoon
    Kim, Mi-Na
    [J]. FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [8] Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis
    Catanzaro, Donald G.
    Trollip, Andre P.
    Seifert, Marva
    Georghiou, Sophia B.
    Garfein, Richard S.
    Rodwell, Timothy C.
    Catanzaro, Antonino
    Eisenach, Kathleen D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (04)
  • [9] Rapid First- and Second-Line Drug Susceptibility Assay for Mycobacterium tuberculosis Isolates by Use of Quantitative PCR
    Pholwat, Suporn
    Heysell, Scott
    Stroup, Suzanne
    Foongladda, Suporn
    Houpt, Eric
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (01) : 69 - 75
  • [10] Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan
    Javaid, A.
    Hasan, R.
    Zafar, A.
    Chaudry, M. A.
    Qayyum, S.
    Qadeer, E.
    Shaheen, Z.
    Agha, N.
    Rizvi, N.
    Afridi, M. Z.
    Chima, M. K.
    Khan, A. R.
    Ghafoor, A.
    Khan, S.
    Awan, S. R.
    Akttar, S.
    Choudry, K.
    Lqba, Z. H.
    Ansarie, M.
    Ahmad, N.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (03) : 303 - 308